|
|
|
Insider
Information: |
Schoemaker Kathleen K |
Relationship: |
10% Owner |
City: |
Princeton |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
24 |
|
Direct
Shares |
8,715,548 |
|
Indirect Shares
|
3,038,103 |
|
|
Direct
Value |
$228,247,061 |
|
|
Indirect Value
|
$11,224,701 |
|
|
Total
Shares |
11,753,651 |
|
|
Total
Value |
$239,471,762 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Senomyx Inc |
SNMX |
10% Owner |
|
0 |
2004-06-25 |
19,603 |
Premium* |
|
Nuvasive Inc |
NUVA |
10% Owner |
|
0 |
2004-05-18 |
31,204 |
Premium* |
|
Santarus Inc |
SNTS |
10% Owner |
2004-04-06 |
0 |
2004-04-06 |
64,471 |
Premium* |
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
10% Owner |
|
0 |
2006-12-21 |
19,379 |
Premium* |
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
2006-04-18 |
0 |
2006-12-12 |
21,068 |
Premium* |
|
Northstar Neuroscience Inc |
NSTR |
10% Owner |
|
0 |
2006-05-10 |
37,586 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
|
0 |
2009-01-30 |
67,875 |
Premium* |
|
Volcano Corp |
VOLC |
10% Owner |
2008-04-24 |
29,887 |
2008-07-16 |
62,513 |
Premium* |
|
Cadence Pharmaceuticals Inc |
CADX |
10% Owner |
2014-02-12 |
2,972,678 |
2014-03-19 |
0 |
Premium* |
|
Orexigen Therapeutics, Inc. |
OREX |
10% Owner |
2007-11-27 |
9,058 |
2011-12-22 |
50,643 |
Premium* |
|
Alimera Sciences Inc |
ALIM |
10% Owner |
2014-01-16 |
3,590,931 |
2011-06-02 |
40,790 |
Premium* |
|
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
|
0 |
2013-01-18 |
244,057 |
Premium* |
|
Zogenix, Inc. |
ZGNX |
10% Owner |
2010-11-29 |
0 |
2011-09-16 |
169,251 |
Premium* |
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2013-06-04 |
44,034 |
2011-11-21 |
51,013 |
Premium* |
|
Durata Therapeutics, Inc. |
DRTX |
10% Owner |
|
0 |
2012-07-24 |
22,306 |
Premium* |
|
Esperion Therapeutics, Inc. |
ESPR |
10% Owner |
|
0 |
2013-07-01 |
35,253 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2013-07-15 |
0 |
2013-07-15 |
1,920,730 |
Premium* |
|
Tobira Therapeutics Inc |
TBRA |
10% Owner |
|
0 |
2013-08-27 |
32,091 |
Premium* |
|
Evoke Pharma Inc |
EVOK |
10% Owner |
|
0 |
2013-09-30 |
24,256 |
Premium* |
|
Veracyte, Inc. |
VCYT |
10% Owner |
2013-11-04 |
0 |
2013-11-04 |
22,730 |
Premium* |
|
Tandem Diabetes Care Inc |
TNDM |
10% Owner |
2013-11-19 |
0 |
2013-11-19 |
54,390 |
Premium* |
|
Dicerna Pharmaceuticals Inc |
DRNA |
10% Owner |
2014-02-04 |
0 |
2014-02-04 |
13,004 |
Premium* |
|
Achaogen Inc |
AKAO |
10% Owner |
2014-03-17 |
0 |
2014-03-17 |
33,890 |
Premium* |
|
Glaukos Corp |
GKOS |
10% Owner |
2015-06-30 |
2,068,960 |
2015-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
282 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 11 of 12
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2013-01-24 |
4/A |
AS |
$5.45 |
$610,520 |
D/D |
(112,022) |
8,098,137 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2011-12-22 |
4 |
B |
$1.45 |
$680,263 |
I/I |
469,147 |
50,643 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-12-17 |
4 |
B |
$7.55 |
$755,000 |
I/I |
100,000 |
42,122 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-08-11 |
4 |
B |
$7.60 |
$792,680 |
I/I |
104,300 |
20,887 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-23 |
4 |
B |
$6.93 |
$1,039,500 |
I/I |
150,000 |
39,606 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2008-12-08 |
4 |
B |
$4.47 |
$1,110,397 |
I/I |
248,411 |
4,173 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2008-12-09 |
4 |
B |
$4.93 |
$1,192,518 |
I/I |
241,890 |
8,237 |
1.5 |
- |
|
ALIM |
Alimera Sciences Inc |
10% Owner |
|
2014-01-16 |
4 |
AS |
$6.56 |
$1,340,306 |
D/D |
(204,315) |
3,590,931 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-11-20 |
4 |
B |
$6.93 |
$1,732,500 |
I/I |
250,000 |
37,090 |
1.5 |
- |
|
CLVS |
Clovis Oncology, Inc. |
10% Owner |
|
2013-03-06 |
4 |
S |
$24.51 |
$2,410,534 |
D/D |
(98,349) |
2,740,937 |
0 |
- |
|
PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
|
2006-05-15 |
4 |
B |
$6.50 |
$2,999,997 |
I/I |
461,538 |
98,075 |
1.5 |
- |
|
TBRA |
Tobira Therapeutics Inc |
10% Owner |
|
2013-08-27 |
4 |
B |
$4.00 |
$3,000,000 |
I/I |
750,000 |
2,571,117 |
1.5 |
- |
|
CLVS |
Clovis Oncology, Inc. |
10% Owner |
|
2013-03-05 |
4 |
S |
$24.69 |
$3,132,371 |
D/D |
(126,868) |
2,839,286 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-08-12 |
4 |
B |
$8.00 |
$3,200,000 |
I/I |
400,000 |
27,595 |
1.5 |
- |
|
ESPR |
Esperion Therapeutics, In... |
10% Owner |
|
2013-07-01 |
4 |
B |
$14.00 |
$3,999,996 |
I/I |
285,714 |
35,253 |
1.5 |
- |
|
ALIM |
Alimera Sciences Inc |
10% Owner |
|
2010-04-27 |
4 |
B |
$11.00 |
$4,158,308 |
I/I |
378,028 |
4,829,773 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2009-07-23 |
4 |
B |
$7.50 |
$4,875,000 |
I/I |
650,000 |
19,138 |
1.5 |
- |
|
OREX |
Orexigen Therapeutics, In... |
10% Owner |
|
2007-05-01 |
4 |
B |
$12.00 |
$6,300,000 |
I/I |
525,000 |
104,975 |
1.5 |
- |
|
ZGNX |
Zogenix, Inc. |
10% Owner |
|
2011-09-16 |
4 |
B |
$2.00 |
$7,000,000 |
I/I |
3,500,000 |
169,251 |
1.5 |
- |
|
DRTX |
Durata Therapeutics, Inc. |
10% Owner |
|
2012-07-24 |
4 |
B |
$9.00 |
$7,058,817 |
I/I |
784,313 |
22,306 |
1.5 |
- |
|
OCRX |
Ocera Therapeutics Inc |
10% Owner |
|
2013-07-15 |
4/A |
B |
$6.03 |
$7,999,992 |
I/I |
1,327,491 |
1,857,036 |
1.5 |
- |
|
OCRX |
Ocera Therapeutics Inc |
10% Owner |
|
2013-07-15 |
4 |
B |
$6.03 |
$7,999,992 |
I/I |
1,327,491 |
1,897,336 |
1.5 |
- |
|
ZGNX |
Zogenix, Inc. |
10% Owner |
|
2010-11-29 |
4 |
B |
$4.00 |
$9,399,996 |
I/I |
2,349,999 |
110,555 |
1.5 |
- |
|
CLVS |
Clovis Oncology, Inc. |
10% Owner |
|
2013-06-04 |
4 |
S |
$64.58 |
$10,280,619 |
D/D |
(159,192) |
2,581,745 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2014-02-12 |
4 |
OE |
$7.84 |
$10,717,437 |
D/D |
1,367,020 |
3,738,210 |
0 |
- |
|
282 Records found
|
|
Page 11 of 12 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|